Welcome to CMEZone

CMEZone.com is a full-service web solution that provides timely, practical, and clinically relevant continuing education for health care professionals. All CMEZone activities are designed to enhance clinical knowledge and competence and to improve patient care.

More than 100,000 health care professionals maintain membership in CMEZone in order to access continuing education activities on demand. All activities are easily accessible, free of charge and offer participants instantaneous post-test grading and printable certificates of completion.

CMEZone is operated by Applied Clinical Education (ACE). As an advocate of lifelong learning and supporter of applied learning strategies, ACE is dedicated to providing education that strengthens performance and enhances the clinical care of patients.

Participant Login


Remember Me
Lost your password? New user? Register here

Jointly sponsored by Global Education Group and Applied Clinical Education

  • GEGLogo
  • CMEZoneLogo

Supported by an educational grant from

  • CovidenLogo

The REMEDIES Coalition also includes

  • ASPELogo
  • iMDLogo
  • MedMatrxLogo
  • NAMCPLogo
  • REALCMELogo

 



Individuals who suffer from severe chronic pain are caught in a double bind. Opioids contribute to the enormous societal harms of unintentional overdose, divers... Researchers reporting in Anesthesiology have found a protein compound that appears to play a role in the development of opioid tolerance; the... The FDA has cleared a 510(k) premarketing application for StimRouter, an implantable neuromodulation device designed to treat chronic pain of peripheral nerve o... First, and most obviously, although I am sure there are certain areas in health care where in the short term we can improve quality and reduce cost, there is&nb... Knowing average intraoperative anesthesia ready times could help hospital administrators and anesthesiology departments improve intraoperative efficiency with b... Pfizer announced that the FDA has accepted for review the New Drug Application (NDA) for ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride), extended...